DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label Methyl 2-amino-4-(trifluoromethyl)benzoate. Show all posts
Showing posts with label Methyl 2-amino-4-(trifluoromethyl)benzoate. Show all posts

Thursday, 12 March 2015

Methyl 2-amino-4-(trifluoromethyl)benzoate

Methyl 2-amino-4-(trifluoromethyl)benzoate
Methyl 2-amino-4-(trifluoromethyl)benzoate

61500-87-6 CAS
Synonyms:



1H NMR (DMSO-d6) δ 3.79 (s, 3h), 6.75 (dd, j=1.84, 8.46 hz, 1H), 6.96 (br s, 2h), 7.11 (d, j=0.73 hz, 1H), 7.83 (d, j=8.09 hz, 1H)



logo
methyl 2-amino-4-(trifluoromethyl)benzoate NMR spectra analysis, Chemical CAS NO. 61500-87-6 NMR spectral analysis, methyl 2-amino-4-(trifluoromethyl)benzoate H-NMR spectrum

logo

13 C NMR PREDICT

methyl 2-amino-4-(trifluoromethyl)benzoate NMR spectra analysis, Chemical CAS NO. 61500-87-6 NMR spectral analysis, methyl 2-amino-4-(trifluoromethyl)benzoate C-NMR spectrum


COSY PREDICT







SYNTHESIS

Hill; Stanley; Karoglan Williams; Loev; Fowler; McCafferty; Macko; Berkoff; Ladd Journal of Medicinal Chemistry, 1983 , vol. 26, # 6 p. 865 - 869

ELI LILLY AND COMPANY Patent: WO2006/2342 A1, 2006 ; Location in patent: Page/Page column 55-56 ;


European Journal of Medicinal Chemistry, , vol. 40, # 9 p. 897 - 907



https://www.google.com/patents/WO2006002342A1?cl=en

Preparation of Methyl 2-amino-4-trifluoromethylbenzoate.
Figure imgf000058_0001
Add a solution of methyl 2-nitro-4-trifluoromethylbenzoate (106 g, 425 mmol) in ethyl acetate (2.2 L) to a slurry of 10% palladium on carbon (11.0 g) in ethyl acetate (200 mL) and stir the suspension at room temperature under an atmosphere of hydrogen at 60 psi for 3 h. Filter the suspension through a pad of Celite® and wash the pad with additional ethyl acetate. Remove the solvents under reduced pressure and purify the residue by column chromatography on silica gel, eluting with isohexane/ethyl acetate (9:1), to provide the title compound as a white crystalline solid (84 g, 95%). 
1H NMR (300 MHz, CD3OD)
 δ 7.93 (d, / = 8.48 Hz, IH), 
7.06 (s, IH), 
6.78 (s, IH), 
4.86 (s, 3H), NH2  MAYBE
3.89 (s, 3H).